rs76249490

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020247.5(COQ8A):​c.238C>T​(p.His80Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00235 in 1,614,012 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. H80H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0025 ( 9 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 78 hom. )

Consequence

COQ8A
NM_020247.5 missense

Scores

3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.75

Publications

9 publications found
Variant links:
Genes affected
COQ8A (HGNC:16812): (coenzyme Q8A) This gene encodes a mitochondrial protein similar to yeast ABC1, which functions in an electron-transferring membrane protein complex in the respiratory chain. It is not related to the family of ABC transporter proteins. Expression of this gene is induced by the tumor suppressor p53 and in response to DNA damage, and inhibiting its expression partially suppresses p53-induced apoptosis. Alternatively spliced transcript variants have been found; however, their full-length nature has not been determined. [provided by RefSeq, Jul 2008]
COQ8A Gene-Disease associations (from GenCC):
  • autosomal recessive ataxia due to ubiquinone deficiency
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • coenzyme Q10 deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029934943).
BP6
Variant 1-226965060-C-T is Benign according to our data. Variant chr1-226965060-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 214026.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00248 (378/152358) while in subpopulation EAS AF = 0.0465 (241/5180). AF 95% confidence interval is 0.0417. There are 9 homozygotes in GnomAd4. There are 226 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COQ8ANM_020247.5 linkc.238C>T p.His80Tyr missense_variant Exon 3 of 15 ENST00000366777.4 NP_064632.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COQ8AENST00000366777.4 linkc.238C>T p.His80Tyr missense_variant Exon 3 of 15 1 NM_020247.5 ENSP00000355739.3
ENSG00000288674ENST00000366779.6 linkn.*4965C>T non_coding_transcript_exon_variant Exon 20 of 32 2 ENSP00000355741.2
ENSG00000288674ENST00000366779.6 linkn.*4965C>T 3_prime_UTR_variant Exon 20 of 32 2 ENSP00000355741.2

Frequencies

GnomAD3 genomes
AF:
0.00249
AC:
379
AN:
152240
Hom.:
9
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.0466
Gnomad SAS
AF:
0.0207
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00661
AC:
1660
AN:
251282
AF XY:
0.00687
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000173
Gnomad ASJ exome
AF:
0.000894
Gnomad EAS exome
AF:
0.0529
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.0000880
Gnomad OTH exome
AF:
0.00424
GnomAD4 exome
AF:
0.00233
AC:
3410
AN:
1461654
Hom.:
78
Cov.:
32
AF XY:
0.00277
AC XY:
2013
AN XY:
727126
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33480
American (AMR)
AF:
0.000179
AC:
8
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000880
AC:
23
AN:
26136
East Asian (EAS)
AF:
0.0360
AC:
1428
AN:
39700
South Asian (SAS)
AF:
0.0189
AC:
1628
AN:
86258
European-Finnish (FIN)
AF:
0.0000752
AC:
4
AN:
53190
Middle Eastern (MID)
AF:
0.00173
AC:
10
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000576
AC:
64
AN:
1112010
Other (OTH)
AF:
0.00402
AC:
243
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
233
465
698
930
1163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00248
AC:
378
AN:
152358
Hom.:
9
Cov.:
33
AF XY:
0.00303
AC XY:
226
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.000192
AC:
8
AN:
41584
American (AMR)
AF:
0.000261
AC:
4
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.0465
AC:
241
AN:
5180
South Asian (SAS)
AF:
0.0207
AC:
100
AN:
4832
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
68030
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00197
Hom.:
13
Bravo
AF:
0.00238
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.00640
AC:
777
Asia WGS
AF:
0.0330
AC:
115
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 05, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

COQ8A: BP4, BS1, BS2

Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2
Dec 03, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Jun 25, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive ataxia due to ubiquinone deficiency Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Jan 07, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive cerebellar ataxia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
14
DANN
Uncertain
0.98
DEOGEN2
Benign
0.096
T;.;T
Eigen
Benign
-0.57
Eigen_PC
Benign
-0.50
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.0
.;T;T
MetaRNN
Benign
0.0030
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
.;.;.
PhyloP100
1.8
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.79
N;N;N
REVEL
Benign
0.085
Sift
Benign
0.035
D;D;D
Sift4G
Uncertain
0.037
D;D;D
Vest4
0.096
ClinPred
0.015
T
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.038
gMVP
0.20
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76249490; hg19: chr1-227152761; COSMIC: COSV64656787; API